(Q38224182)

31 August 2017

title

Emerging applications for ferumoxytol as a contrast agent in MRI. (English)

1 reference

magnetic resonance imaging

31 August 2017

1 reference

0 references

author name string

Mustafa R Bashir

1

1 reference

31 August 2017

Lubna Bhatti

2

1 reference

31 August 2017

Daniele Marin

3

1 reference

31 August 2017

Rendon C Nelson

4

1 reference

31 August 2017

publication date

30 June 2014

1 reference

Journal of Magnetic Resonance Imaging

31 August 2017

published in

1 reference

31 August 2017

volume

41

1 reference

31 August 2017

issue

4

1 reference

31 August 2017

page(s)

884-898

1 reference

Magnetic resonance angiographic techniques for the diagnosis of arterial disease

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

State-of-the-art aortic imaging: part I - fundamentals and perspectives of CT and MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Coarctation of the abdominal aorta: demonstration of a rare anomaly using contrast-enhanced MR-angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

MR contrast agents for liver imaging: what, when, how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

MR angiography with blood pool contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Simultaneous MR arteriography and venography with blood pool contrast agent detects deep venous thrombosis in suspected arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Nephrogenic systemic fibrosis: risk factors and incidence estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Recent advances in iron oxide nanocrystal technology for medical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Parenteral ferumoxytol interaction with magnetic resonance imaging: a case report, review of the literature and advisory warning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Ferumoxytol in clinical practice: implications for MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Comparison of rates of reported adverse events associated with i.v. iron products in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Imaging of Pregnant and Lactating Patients: Part 1, Evidence-Based Review and Recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Blood pool MR angiography of aortic stent-graft endoleak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

MR angiography of the renal arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Transplant renal artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Multiple hepatic adenomas: Tc-99m RBC liver SPECT findings with pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Technetium-99m-labelled red blood cell imaging in the diagnosis of hepatic haemangiomas: the role of SPECT/CT with a hybrid camera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Usefulness of Tc-99m RBC SPECT/MRI fusion imaging in small suspected hepatic hemangiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Management of incidentally discovered intracranial vascular abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Biology of intracranial aneurysms: role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Imaging aspirin effect on macrophages in the wall of human cerebral aneurysms using ferumoxytol-enhanced MRI: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Evidence of inflammatory cell involvement in brain arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Interleukin-6 involvement in brain arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Plaque inflammation and unstable morphology are associated with early stroke recurrence in symptomatic carotid stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Molecular imaging of vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Stabilization of atherosclerotic plaques: new mechanisms and clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Cytocidal effects of atheromatous plaque components: the death zone revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Long-term outcome after pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

MRI of transplanted pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Quantification of islet loss and graft functionality during immune rejection by 3-tesla MRI in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Iron administration before stem cell harvest enables MR imaging tracking after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10–enhanced MR Imaging: Phase III Safety and Efficacy Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

Subclavian MR Arteriography: Reduction of Susceptibility Artifact with Short Echo Time and Dilute Gadopentetate Dimeglumine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24691

21 January 2018

Identifiers

DOI

10.1002/JMRI.24691

1 reference

31 August 2017

1 reference